Mayumi Mukai Selected Research

KHK4083

1/2021

A Phase 1 Study of KHK4083: A Single-Blind, Randomized, Placebo-Controlled Single-Ascending-Dose Study in Healthy Adults and an Open-Label Multiple-Dose Study in Patients With Ulcerative Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mayumi Mukai Research Topics

Disease

3	Papillary Thyroid Cancer 11/2014 - 01/2010
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2020 - 01/2020
2	Mycosis Fungoides 01/2020 - 01/2020
2	Carcinogenesis 01/2010 - 09/2008
1	Ulcerative Colitis 01/2021
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Neoplasms (Cancer) 11/2014
1	Thyroid Neoplasms (Thyroid Cancer) 01/2010

Drug/Important Bio-Agent (IBA)

2	mogamulizumabIBA 01/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 01/2020
2	CC ChemokinesIBA 01/2020 - 01/2020
2	Complementary DNA (cDNA)IBA 11/2014 - 01/2010
1	KHK4083IBA 01/2021
1	CreatinineIBA 01/2020
1	BilirubinIBA 01/2020
1	istradefyllineIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	Anaplastic Lymphoma KinaseIBA 11/2012
1	Formaldehyde (Formol)FDA Link 01/2010
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2010
1	RNA (Ribonucleic Acid)IBA 01/2010
1	ParaffinIBA 01/2010
1	Mitogen-Activated Protein KinasesIBA 09/2008